A study for a 76 year old woman who takes Hydroxyurea - from FDA reports


1,076 females aged 76 (±5) who take the same drug are studied. This is a personalized study for a 76 year old female patient who has Cancer. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Dec, 05, 2018

1,076 females aged 76 (±5) who take Hydroxyurea are studied.


Number of reports submitted per year:

Hydroxyurea for a 76-year old woman.

Information of the patient in this study:

  • Age: 76
  • Gender: female
  • Conditions: Cancer
  • Drugs taken:
    • Hydroxyurea (hydroxyurea)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Cardiac Arrest: 4 (0.37% of females aged 76 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  1. Nausea (feeling of having an urge to vomit)
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Heart attack
  4. Nausea and vomiting
  5. Fatigue (feeling of tiredness)
1 - 6 months:
  1. Thrombocytopenia (decrease of platelets in blood)
  2. Anaemia (lack of blood)
  3. Fatigue (feeling of tiredness)
  4. Heart palpitations (feelings or sensations that your heart is pounding or racing)
  5. Nausea (feeling of having an urge to vomit)
6 - 12 months:
  1. Thrombocytopenia (decrease of platelets in blood)
  2. Anaemia (lack of blood)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Electrocardiogram qt prolonged
  5. Rashes (redness)
1 - 2 years:
  1. Nightmares (unpleasant dreams)
  2. Impaired healing
  3. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  4. Wound
  5. Subdural haematoma (blood collects between the skull and the surface of the brain)
2 - 5 years:
  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  2. Lung infection
  3. Headache (pain in head)
  4. Skin ulcer
  5. Malignant neoplasm progression (cancer tumour came back)
5 - 10 years:
  1. Fever
  2. Rash erythematous (redness of the skin)
  3. Cutaneous lupus erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms)
  4. Skin ulcer
  5. Pleural effusion (water on the lungs)
10+ years:
  1. Altered state of consciousness (altered state of mind)
  2. Accidental overdose (therapeutic agent)
  3. Melaena (the passage of black, tarry stools)
  4. Pain in extremity
  5. Diarrhea
not specified:
  1. Fatigue (feeling of tiredness)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Anaemia (lack of blood)
  4. Nausea (feeling of having an urge to vomit)
  5. Breathing difficulty

Top conditions involved for these people *:

  1. Essential Thrombocythaemia (chronic blood cancer): 115 people, 10.69%
  2. High Blood Pressure : 94 people, 8.74%
  3. Primary Myelofibrosis (primary disorder of the bone marrow): 94 people, 8.74%
  4. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 85 people, 7.90%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 62 people, 5.76%

Top co-used drugs for these people *:

  1. Jakafi (147 people, 13.66%)
  2. Lasix (72 people, 6.69%)
  3. Allopurinol (69 people, 6.41%)
  4. Aspirin (67 people, 6.23%)
  5. Synthroid (58 people, 5.39%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:



Related studies:

Related publications that referenced our studies

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!